Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-18T19:19:08.518Z Has data issue: false hasContentIssue false

CS03-04 - The Economic Consequences of Comorbid Diabetes and Depression

Published online by Cambridge University Press:  17 April 2020

M. Knapp*
Affiliation:
Centre for the Economics of Mental Health, Institute of Psychiatry, London, UK Personal Social Services Research Unit, London School of Economics and Political Science, London, UK

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Diabetes and depression on their own are debilitating and costly diseases. Their co-existance presents further treatment and funding challenges. This session will provide an overview of the economic dimensions of this comorbid relationship and present the findings of a systematic review of evidence related to this. The review found a growing literature demonstrating: increased resource use and health care costs, unemployment and lost productivity; poorer quality of life; and a higher risk of mortality arising from the co-existance of these illnesses. While there are some good quality studies evaluating the efficacy/effectiveness of various treatments, few include an economic evaluation and the generalisability of those is unclear. Therefore, while the evidence suggests little doubt of the broad-ranging economic impacts on patients, health care systems and wider society, there is still a gap regarding the cost-effectiveness of alternative approaches to the treatment and long-term management of this comorbidity within the context of limited health care budgets.

Type
Co-morbidity of diabetes and depression: problems for science and consequences for parctice
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.